Skip to main content
BAK
NYSE Industrial Applications And Services

Braskem 3Q26: R$3.37B Nine-Month Profit, But Auditor Flags Going-Concern Doubt

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Negative
Importance info
9
Price
$1.13
Mkt Cap
$478.972M
52W Low
$0.743
52W High
$5.395
52W Position info
52% above low
Off High info
79% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

BAK sits 52% above its 52-week low of $0.743.

Summary

Braskem posted a R$3,374 million nine-month profit on FX and derivative gains, but the 3Q26 statements carry a going-concern emphasis: negative equity of R$14,213 million, negative working capital of R$50,611 million and negative operating cash flow of R$3,238 million while restructuring negotiations continue.


Key Events · Earnings and Guidance · BAK

  • Nine-Month Profit Driven by FX Gains

    Consolidated net revenue was R$56,787 million and net profit R$3,374 million (R$3,703 million to shareholders), versus R$68 million a year earlier; the swing came largely from R$3,629 million of net derivatives and exchange-rate variations, while financial expenses of R$5,118 million exceeded gross profit of R$8,418 million.

  • Auditor Flags Going-Concern Uncertainty

    Deloitte's review report includes an emphasis of matter citing negative shareholders' equity of R$14,213 million consolidated (R$13,616 million parent), negative net working capital of R$50,611 million consolidated and negative operating cash flow of R$3,238 million consolidated.

  • Debt Reclassified to Current Liabilities

    Borrowings and debentures jumped to R$52,400 million in current liabilities from R$8,268 million at Dec/25 after covenant non-compliance and cross-default triggers; cash and equivalents fell to R$6,010 million from R$10,501 million.

  • Restructurings Await Creditor and Court Sign-Off

    The out-of-court plan covers about R$56.4 billion (US$10.9 billion) of unsecured claims and needs accession above half plus court ratification; Braskem Idesa's prepackaged Chapter 11 plan was confirmed at the 09/22/2026 hearing, with ~R$8,165 million (US$1,576 million) of 9.25% Exit Notes and Braskem Group's stake falling from 75% to 58.33% on the Effective Date.


Analysis · BAK · Industrial Applications And Services

Braskem's 3Q26 report shows a swing to a R$3,374 million nine-month profit from R$68 million a year earlier, driven mainly by R$3,629 million of net derivatives and FX gains rather than operations — gross profit of R$8,418 million still does not cover R$5,118 million of financial expenses. The balance sheet is the real story: consolidated shareholders' equity is negative R$14,213 million, net working capital is negative R$50,611 million after R$52,400 million of borrowings were pushed into current liabilities, and operating cash flow was negative R$3,238 million. Deloitte's review carries an explicit going-concern emphasis, and the out-of-court restructuring still needs creditor accession above half of the R$56.4 billion subject claims plus court ratification, while Braskem Idesa's Chapter 11 plan awaits its Effective Date. Cash fell to R$6,010 million from R$10,501 million, and a US$950 million stand-by facility matures in December 2026 — the near-term liquidity test.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 49.5% of the 210 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BAK was trading at $1.13 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $479M. The 52-week trading range was $0.74 to $5.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BAK - Latest Insights

BAK
Nov 12, 2026, 7:18 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $1.13 info
Change: +$0.0699 (+7%) info
Market Cap: $478.972M info
BAK
Nov 10, 2026, 8:27 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.10
Real-time Price: $1.13 info
Change: +$0.030 (+3%) info
Market Cap: $478.972M info
BAK
Nov 06, 2026, 7:58 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.09
Real-time Price: $1.13 info
Change: +$0.040 (+4%) info
Market Cap: $478.972M info
BAK
Oct 29, 2026, 8:19 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.11
Real-time Price: $1.13 info
Change: +$0.020 (+2%) info
Market Cap: $478.972M info
BAK
Oct 27, 2026, 9:53 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.34
Real-time Price: $1.13 info
Change: -$0.210 (-16%) info
Market Cap: $478.972M info